It was known that TSC1 or TSC2 gene mutations in TSC patients may cause the neurodegeneration and the development of benign tumors, such as liver or renal angiomyolipomas, renal cell carcinomas, and hamartomas et al. [11–13]. This evidence concerns the gene TSC1 and hamartoma.